Monday, July 14, 2008

TG2 identified as potential therapeutic target in chemo-resistant

For example, TG2 overexpression causes the degradation of the tumor-suppressing protein PTEN in pancreatic cancer, Mehta and colleagues reported in Clinical ...

Nanoparticles Stops Spread Of Kidney And Pancreatic Cancer Without ...AHN - Jul 11, 2008... that deliver drug agents to stop pancreatic and kidney cancer from spreading in mice but have fewer side effects than traditional chemotherapy.

No comments: